Correlation Between SANOFI S and India Glycols

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SANOFI S and India Glycols at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SANOFI S and India Glycols into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SANOFI S HEALTHC and India Glycols Limited, you can compare the effects of market volatilities on SANOFI S and India Glycols and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SANOFI S with a short position of India Glycols. Check out your portfolio center. Please also check ongoing floating volatility patterns of SANOFI S and India Glycols.

Diversification Opportunities for SANOFI S and India Glycols

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between SANOFI and India is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding SANOFI S HEALTHC and India Glycols Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on India Glycols Limited and SANOFI S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SANOFI S HEALTHC are associated (or correlated) with India Glycols. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of India Glycols Limited has no effect on the direction of SANOFI S i.e., SANOFI S and India Glycols go up and down completely randomly.

Pair Corralation between SANOFI S and India Glycols

Assuming the 90 days trading horizon SANOFI S HEALTHC is expected to under-perform the India Glycols. But the stock apears to be less risky and, when comparing its historical volatility, SANOFI S HEALTHC is 1.67 times less risky than India Glycols. The stock trades about -0.01 of its potential returns per unit of risk. The India Glycols Limited is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  69,054  in India Glycols Limited on September 12, 2024 and sell it today you would earn a total of  78,276  from holding India Glycols Limited or generate 113.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy18.94%
ValuesDaily Returns

SANOFI S HEALTHC  vs.  India Glycols Limited

 Performance 
       Timeline  
SANOFI S HEALTHC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SANOFI S HEALTHC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, SANOFI S is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
India Glycols Limited 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in India Glycols Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, India Glycols disclosed solid returns over the last few months and may actually be approaching a breakup point.

SANOFI S and India Glycols Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SANOFI S and India Glycols

The main advantage of trading using opposite SANOFI S and India Glycols positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SANOFI S position performs unexpectedly, India Glycols can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in India Glycols will offset losses from the drop in India Glycols' long position.
The idea behind SANOFI S HEALTHC and India Glycols Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.